Trepulmix الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

trepulmix

scipharm sàrl - treprostinil nátrium - magas vérnyomás, pulmonalis - antitrombotikus szerek - treatment of adult patients with who functional class (fc) iii or iv and:inoperable chronic thromboembolic pulmonary hypertension (cteph), orpersistent or recurrent cteph after surgical treatmentto improve exercise capacity.

Lumoxiti الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

lumoxiti

astrazeneca ab - moxetumomab pasudotox - leukémia, szőrös sejt - daganatellenes szerek - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).

BeneFIX الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

benefix

pfizer europe ma eeig - alfa-nonakogra - b hemofília - antihaemorrhagiás - a vérzés kezelésére és megelőzésére b hemofília (veleszületett ix faktor hiány).

Qdenga الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue-láz - a vakcinák - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Ninlaro الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

ninlaro

takeda pharma a/s - ixazomib citrátot - myeloma multiplex - daganatellenes szerek - a lenlidomiddal és a dexametazonnal kombinációban szenvedő ninlaro jelzett többszörös mielóma felnőtt betegek kezelésére, akik legalább egy korábbi terápiát kaptak.